CK18 and FGF21 are valuable for diagnosing NAFLD; LCN2 and PAI1 may help distinguish NAFL from NASH with relatively high diagnostic value. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatohepatitis.